KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to $4.6 million.

  • LifeMD's Change in Accured Expenses fell 2484.07% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$319253.0, marking a year-over-year decrease of 10478.31%. This contributed to the annual value of $8.0 million for FY2024, which is 7140.69% up from last year.
  • LifeMD's Change in Accured Expenses amounted to $4.6 million in Q3 2025, which was down 2484.07% from -$3.1 million recorded in Q2 2025.
  • LifeMD's Change in Accured Expenses' 5-year high stood at $6.2 million during Q3 2024, with a 5-year trough of -$3.1 million in Q2 2025.
  • Over the past 5 years, LifeMD's median Change in Accured Expenses value was $771146.0 (recorded in 2021), while the average stood at $1.0 million.
  • In the last 5 years, LifeMD's Change in Accured Expenses surged by 134026.49% in 2023 and then crashed by 165947.4% in 2025.
  • Quarter analysis of 5 years shows LifeMD's Change in Accured Expenses stood at $771146.0 in 2021, then increased by 28.83% to $993498.0 in 2022, then tumbled by 193.85% to -$932374.0 in 2023, then surged by 144.26% to $412706.0 in 2024, then skyrocketed by 1022.66% to $4.6 million in 2025.
  • Its last three reported values are $4.6 million in Q3 2025, -$3.1 million for Q2 2025, and -$2.3 million during Q1 2025.